Journal
Therapeutic Advances in Infectious Disease
Publication Date
5-10-2025
Volume
12
First Page
20499361251339300
Document Type
Open Access Publication
DOI
10.1177/20499361251339300
Rights and Permissions
Mejia-Chew C, Spec A, Walton AH, Ulezko Antonova A, Dram A, Bhalla S, Colonna M, Morre M, Hotchkiss R. Recombinant interleukin-7 treatment of refractory Mycobacterium avium complex lung disease (IMPULSE-7): a pilot phase II, single-center, randomized, clinical trial. Ther Adv Infect Dis. 2025 May 10;12:20499361251339300. doi: 10.1177/20499361251339300. © The Author(s), 2025. Creative Commons License (CC BY-NC 4.0) This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License (https://creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage).
Recommended Citation
Mejia-Chew, Carlos; Spec, Andrej; Walton, Andrew H; Ulezko Antonova, Alina; Dram, Alexandra; Bhalla, Sanjeev; Colonna, Marco; Morre, Michel; and Hotchkiss, Richard, "Recombinant interleukin-7 treatment of refractory refractory Mycobacterium avium complexlung disease (IMPULSE-7): A pilot phase II, single-center, randomized, clinical trial." Therapeutic Advances in Infectious Disease. 12, 20499361251339300 (2025).
https://digitalcommons.wustl.edu/oa_4/5429
Department
ICTS (Institute of Clinical and Translational Sciences)
Additional Links
Supplemental material is available for this article at publisher site.
